Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Visiopharm Earns Acclaim from Frost & Sullivan for Transforming Anatomic Pathology with its Cross-platform Software Solutions 2019-03-21 20:00
VisualDx's Web-based Clinical Decision Support System Acknowledged by Frost & Sullivan as Best in Class 2019-03-21 20:00
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
Research from XJTLU advances RNA modification mapping 2019-03-21 16:42
Fueling the Pharmaceutical Industry by Cutting-edge Design, InnoPack China to be Grandly Held in June 2019-03-21 15:00
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:21
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:20
Beckman Coulter's New Procalcitonin Assay Helps Physicians Accurately Identify Patients at Risk for Progression to Septic Shock 2019-03-21 07:00
3SBio Unveils 2018 Annual Results: Revenue Soars by 22.7%, Normalized Net Profit Soars by 29.0%, R&D Expenses Jumps Over 40% 2019-03-21 00:14
Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer 2019-03-20 18:27
Merck Opens First M Lab™ Collaboration Center in Europe 2019-03-20 17:30
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019 2019-03-20 16:00
P-MEC China to Arrive in June as Shanghai Gathers International Advanced Pharmaceutical Equipment 2019-03-20 15:00
ConnectedLife and Ocean Protocol Partner to combat Parkinson's Disease 2019-03-20 12:30
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says 2019-03-20 08:00
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
ACell Enters Exclusive South Korean Distribution Agreement for Wound Management Product Line 2019-03-19 18:55
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China 2019-03-19 18:30
1 936 937 938 939 940 1634